Delivery Order SPE2DB22D3011-SPE2DB25FP8VE
Award Date
1/22/25
Potential Completion Date
2/12/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of INBRIJA 42 MG INHALATION CAP 60S medication. The $1,294.24 firm fixed price contract was awarded on December 19, 2024 by the Defense Logistics Agency (DLA), which is a component of the Department of Defense that specializes in supply chain management and the procurement of medical supplies. The contract has an ultimate completion date of January 13, 2025 and is not designated as...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,876.50 fixed-price delivery order is for the supply of INBRIJA 42 MG INHALATION CAP 60S, a specialty pharmaceutical product. The contract has a period of performance through September 17, 2024 and is not set-aside. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of INBRIJA 42 MG Inhalation Capsules. The $1,876.50 firm-fixed-price delivery order is not designated as a set-aside contract. The award falls under a broader Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for the supply of a...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product, with a potential value of $1,876.50. This contract has a completion date of March 13, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as a prime contractor to DLA Troop Support Medical, providing a range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563755756 INBRIJA 42 MG INHALATION CAP 60S. The contract has a potential value of $1,251.00 and a performance period through March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with...
This federal contract award, identified as SPE2DX15D1053|SPE2DX25F6ELN, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.36 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, for the supply of 4566624914 - INBRIJA 42 MG INHALATION CAP 60S. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,251 firm fixed-price contract is for the supply of Inbrija 42 mg inhalation capsules, a medication used for the treatment of Parkinson's disease. The award has a period of performance through June 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of INBRIJA 42 MG INHALATION CAP 60S, a pharmaceutical product. The $1,251.00 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 18, 2024. The award is not associated with any set-aside designations. Amerisourcebergen Drug Corp's Corporate Office Division has extensive experience fulfilling...
This federal contract award, valued at $1,661.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,605.83 firm-fixed-price delivery order contract is for the supply of a BREYNA 160-4.5 MCG INHALER 10.3GM medical product, with an ultimate completion date of November 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...